Transforming growth factor-beta in breast cancer: a working hypothesis (Q41096355)

26 September 2017

1 reference

title

Transforming growth factor-beta in breast cancer: a working hypothesis (English)

1 reference

26 September 2017

1 reference

Reiss M

1

1 reference

26 September 2017

Barcellos-Hoff MH

series ordinal

2

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

Breast Cancer Research and Treatment

26 September 2017

1 reference

26 September 2017

45

1 reference

26 September 2017

1

1 reference

26 September 2017

81-95

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1005865812918

26 September 2017

0 references

cites work

Effects of transforming growth factor beta on growth of human mammary epithelial cells in culture

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Regulation of mammary morphogenesis: Evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

TGF beta induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

The role of TGF-beta production in growth inhibition of breast-tumor cells by progestins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Receptors for the TGF-β family

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

The extracellular regulation of growth factor action

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Induction of tenascin in healing wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Tenascin is a stromal marker for epithelial malignancy in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Transforming growth factor-beta activation in irradiated murine mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

TGF-beta receptors and actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

TGF beta signals through a heteromeric protein kinase receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Regulation and role of TGF beta production in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

The pharmacological manipulation of members of the transforming growth factor beta family in the chemoprevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Mechanism of retinoid-induced activation of latent transforming growth factor-? in bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Localization of transforming growth factor-beta isotypes in lesions of the human breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-beta 1 in metastatic human breast cancer: an immunocytochemical study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Mechanisms of tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Clinical tumour markers in lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005865812918

7 January 2021

Identifiers

DOI

10.1023/A:1005865812918

1 reference

Dimensions Publication ID

26 September 2017

0 references

1 reference